Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Investor Daily.
Press releases published on May 23, 2025
Self-driving Cars Market worth 76,217 thousand units in 2032, Globally, at a CAGR of 6.8%, says MarketsandMarkets™
GlobeNewswire
·
May 23, 2025
Delray Beach, FL, May 22, 2025 (GLOBE NEWSWIRE) -- Self-Driving Cars Market is projected to reach from 37,090 thousand units in 2024 to 76,217 thousand units in 2035, at a CAGR of 6.8%, as per the recent study by MarketsandMarkets™. The self-driving cars …
El servicio nacional Drones como un Servicio (DaaS) de ZenaTech crece con el cierre de su quinta adquisición, sumando capacidades de inspección de líneas eléctricas
GlobeNewswire
·
May 23, 2025
VANCOUVER, Columbia Británica, May 22, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), una empresa de tecnología especializada en drones con IA (Inteligencia Artificial), Dron como un Servicio (DaaS), soluciones …
Brompton Split Banc Corp. Renews At-the-Market Equity Program
GlobeNewswire
·
May 23, 2025
Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, May 22, 2025 (GLOBE NEWSWIRE) -- (TSX: SBC, SBC.PR.A) Brompton Split Banc Corp. (the “Fund”) is pleased to announce it has renewed its at-the-market equity …
Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock
GlobeNewswire
·
May 23, 2025
SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced the pricing of its previously announced underwritten public offering of …
Algernon Closes NoBrainer Imaging Centers, Inc. Acquisition
GlobeNewswire
·
May 23, 2025
VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare and clinical stage drug development company, is pleased to announce …